• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: 5-aza-2'-deoxycytidine
Date Designated: 08/03/1987
Orphan Designation: Treatment of acute leukemia.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
SuperGen, Inc.
4140 Dublin Blvd.
Suite 200
Dublin, California 94568
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.